Incidence of posttransplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: ADVANCE, a randomized controlled trial.

No abstract available

from #ENT via xlomafota13 on Inoreader http://ift.tt/2c1wY2H
via IFTTT